K Beiske

Standardization of the immunocytochemical detection of cancer cells in BM and blood: I. establishment of objective criteria for the evaluation of immunostained cells.

G Kvalheim, J. Nesland, B. Naume, 1999, Cytotherapy.

Segmental chromosomal alterations lead to a higher risk of relapse in infants with MYCN-non-amplified localised unresectable/disseminated neuroblastoma (a SIOPEN collaborative study)

O. Delattre, G. Tonini, P. Ambros, 2011, British Journal of Cancer.

Can morphology predict 1p/19q loss in oligodendroglial tumours?

K Skullerud, K. Skullerud, K. Beiske, 2008, Histopathology.

Treatment of children over the age of one year with unresectable localised neuroblastoma without MYCN amplification: results of the SIOPEN study.

A Garaventa, S Parodi, R Haupt, 2013, European journal of cancer.